Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contemporary recommendations for evaluating and treating hyperlipidemia.

R S Perry

    Clinical Pharmacy
    |February 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fermi surface and pseudogap in highly doped Sr<sub>2</sub>IrO<sub>4</sub>.

    npj quantum materials·2025
    Same author

    Strain control of a bandwidth-driven spin reorientation in Ca<sub>3</sub>Ru<sub>2</sub>O<sub>7</sub>.

    Nature communications·2023
    Same author

    Publisher's Note: "z<sup>+</sup>: Neutron cross section separation from wide-angle uniaxial polarization analysis" [Rev. Sci. Instrum. 93, 063902 (2022)].

    The Review of scientific instruments·2022
    Same author

    z<sup>+</sup>: Neutron cross section separation from wide-angle uniaxial polarization analysis.

    The Review of scientific instruments·2022
    Same author

    Magnetic-field-controlled spin fluctuations and quantum critically in Sr<sub>3</sub>Ru<sub>2</sub>O<sub>7</sub>.

    Nature communications·2021
    Same author

    Selective probing of magnetic order on Tb and Ir sites in stuffed Tb<sub>2</sub>Ir<sub>2</sub>O<sub>7 </sub> using resonant x-ray scattering.

    Journal of physics. Condensed matter : an Institute of Physics journal·2019
    Same journal

    Criteria for use of epoetin alfa in adult cancer and orthopedic-surgery patients.

    Clinical pharmacy·1993
    Same journal

    Accuracy of unbound-quinidine concentration determination after ultrafiltration.

    Clinical pharmacy·1993
    Same journal

    Modified Michaelis-Menten equation for estimating unbound-phenytoin concentrations.

    Clinical pharmacy·1993
    Same journal

    Predicting vancomycin pharmacokinetics by using aminoglycoside pharmacokinetics.

    Clinical pharmacy·1993
    Same journal

    Efficacy of nutritional supplements used by athletes.

    Clinical pharmacy·1993
    Same journal

    Low-molecular-weight heparins for the treatment of deep-vein thrombosis.

    Clinical pharmacy·1993
    See all related articles

    Managing hyperlipidemia involves understanding its biochemistry and causes. Effective treatment, including diet and drugs, aims to lower cholesterol and triglyceride levels, especially for coronary artery disease (CAD) risk.

    Area of Science:

    • Biochemistry and clinical management of lipid disorders.

    Background:

    • Hyperlipidemia is a significant risk factor for coronary artery disease (CAD).
    • The role of elevated triglycerides as an independent risk factor for CAD requires further investigation.

    Purpose of the Study:

    • To discuss the biochemistry, etiology, evaluation, and management of hyperlipidemia.
    • To review various dietary and drug therapies for hyperlipidemia.

    Main Methods:

    • Laboratory diagnosis relies on repeated measurement of serum or plasma cholesterol and triglyceride concentrations.
    • Therapeutic goals include reducing lipid levels, modifying co-existing risk factors, and individualizing treatment.
    • Dietary interventions, such as the American Heart Association's three-phase diet, are emphasized.

    Main Results:

    Related Experiment Videos

    • Strong evidence links increased cholesterol to CAD.
    • The link between elevated triglycerides and CAD is less certain.
    • Various drug therapies (e.g., statins, fibrates) are reviewed for their effects on lipids and lipoproteins.

    Conclusions:

    • Hyperlipidemia management requires a systematic approach considering patient-specific factors and treatment limitations.
    • Dietary therapy alone manages most patients.
    • Drug therapy is considered for patients with persistent hyperlipidemia despite dietary efforts, particularly those at high risk for CAD.